-
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Average Recommendation of "Buy" by Analysts
المصدر: Buzz FX / 19 فبراير 2025 01:36:11 America/Chicago
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Average Recommendation of "Buy" by Analysts Written by MarketBeat February 19, 2025 Share Link copied to clipboard. Shares of Tourmaline Bio, Inc. ( NASDAQ:TRML - Get Free Report ) have been assigned
Read more...